Table 2.
Observed toxicity events for patients receiving trastuzumab plus pertuzumab
| CTC Grade | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||||
| Toxicity | N | % | N | % | N | % | N | % |
|
|
|
|
|
|||||
| Hematologic | ||||||||
| Neutropenia | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hemoglobin | 2 | 18 | 0 | 0 | 0 | 0 | 0 | 0 |
| Thrombocytopenia | 2 | 18 | 0 | 0 | 0 | 0 | 0 | 0 |
| Nonhematologic | ||||||||
| Diarrhea | 2 | 18 | 3 | 27 | 0 | 0 | 0 | 0 |
| Allergic reaction | 2 | 18 | 0 | 0 | 1 | 9 | 0 | 0 |
| Rash | 1 | 9 | 0 | 0 | 0 | 0 | 0 | 0 |
| Nail changes | 2 | 18 | 1 | 9 | 0 | 0 | 0 | 0 |
| Left ventricular systolic Dysfunction | 3 | 27 | 2 | 18 | 1 | 9 | 0 | 0 |
N: number of patients.